262 related articles for article (PubMed ID: 29791895)
41. Esomeprazole for the Treatment of GERD in Infants Ages 1-11 Months.
Winter H; Gunasekaran T; Tolia V; Gottrand F; Barker PN; Illueca M
J Pediatr Gastroenterol Nutr; 2015 Jul; 60 Suppl 1():S9-15. PubMed ID: 26422097
[TBL] [Abstract][Full Text] [Related]
42. Effect of acid-suppressive therapy on narrow band imaging findings in gastroesophageal reflux disease: a pilot study.
Lynch CR; Wani S; Rastogi A; Keighley J; Mathur S; Higbee A; Bansal A; Gaddam S; Sharma P
Dis Esophagus; 2013; 26(2):124-9. PubMed ID: 22404535
[TBL] [Abstract][Full Text] [Related]
43. Analysis of Clinical Predictors of Resolution of Sleep Disturbance Related to Frequent Nighttime Heartburn and Acid Regurgitation Symptoms in Individuals Taking Esomeprazole 20 mg or Placebo.
Johnson DA; Le Moigne A; Li J; Pollack C; Nagy P
Clin Drug Investig; 2016 Jul; 36(7):531-8. PubMed ID: 27074935
[TBL] [Abstract][Full Text] [Related]
44. Efficacy of three different dosages of esomeprazole in the long-term management of reflux disease: a prospective, randomized study, using the wireless Bravo pH system.
Vasiliadis KV; Viazis N; Vlachogiannakos J; Sgouros SN; Stefanidis G; Archimandritis A; Karamanolis DG
Am J Gastroenterol; 2010 Feb; 105(2):308-13. PubMed ID: 19809412
[TBL] [Abstract][Full Text] [Related]
45. The impact of illness in patients with moderate to severe gastro-esophageal reflux disease.
El-Dika S; Guyatt GH; Armstrong D; Degl'innocenti A; Wiklund I; Fallone CA; Tanser L; Veldhuyzen van Zanten S; Heels-Ansdell D; Wahlqvist P; Chiba N; Barkun AN; Austin P; Schünemann HJ
BMC Gastroenterol; 2005 Jul; 5():23. PubMed ID: 16004616
[TBL] [Abstract][Full Text] [Related]
46. Effects of esomeprazole 40 mg twice daily on asthma: a randomized placebo-controlled trial.
Kiljander TO; Harding SM; Field SK; Stein MR; Nelson HS; Ekelund J; Illueca M; Beckman O; Sostek MB
Am J Respir Crit Care Med; 2006 May; 173(10):1091-7. PubMed ID: 16357331
[TBL] [Abstract][Full Text] [Related]
47. Commentary: daily pantoprazole vs. esomeprazole for GERD.
Dhaliwal A; Nwokolo C
Aliment Pharmacol Ther; 2014 Jan; 39(2):226. PubMed ID: 24330238
[No Abstract] [Full Text] [Related]
48. Effect of on-demand vs continuous prescription of proton pump inhibitors on symptom burden and quality of life: results of a real-world randomized controlled trial in primary care patients with gastroesophageal reflux disease.
Andreasson A; Agréus L; Mastellos N; Bliźniuk G; Waśko-Czopnik D; Angelaki A; Theodosaki E; Lionis C; Hek K; Verheij R; Wright E; Durbaba S; Muris J; Bródka P; Saganowski S; Ethiér JF; Curcin V; Delaney B
Ann Med; 2024 Dec; 56(1):2354683. PubMed ID: 38753973
[TBL] [Abstract][Full Text] [Related]
49. Effect of proton-pump inhibitor treatment on symptoms and quality of life in GERD patients depends on the symptom-reflux association.
Aanen MC; Weusten BL; Numans ME; de Wit NJ; Samsom M; Smout AJ
J Clin Gastroenterol; 2008; 42(5):441-7. PubMed ID: 18344896
[TBL] [Abstract][Full Text] [Related]
50. [Long-term impact on quality of life in patients with gastroesophageal reflux disease after 52-week rabeprazole treatment].
Yang XL; Liu XH; Ke MY; Song ZQ; Yuan YZ; Luo JY; Hou XH
Zhonghua Yi Xue Za Zhi; 2009 Sep; 89(34):2404-7. PubMed ID: 20137694
[TBL] [Abstract][Full Text] [Related]
51. Effect of mosapride combined with esomeprazole improves esophageal peristaltic function in patients with gastroesophageal reflux disease: a study using high resolution manometry.
Cho YK; Choi MG; Park EY; Lim CH; Kim JS; Park JM; Lee IS; Kim SW; Choi KY
Dig Dis Sci; 2013 Apr; 58(4):1035-41. PubMed ID: 23053900
[TBL] [Abstract][Full Text] [Related]
52. Esomeprazole for the Treatment of GERD in Infants Ages 1-11 Months.
Winter H; Gunasekaran T; Tolia V; Gottrand F; Barker PN; Illueca M
J Pediatr Gastroenterol Nutr; 2015 Jul; 60 Suppl 1():S9-15. PubMed ID: 26121349
[TBL] [Abstract][Full Text] [Related]
53. Effect of esomeprazole on nighttime heartburn and sleep quality in patients with GERD: a randomized, placebo-controlled trial.
Johnson DA; Orr WC; Crawley JA; Traxler B; McCullough J; Brown KA; Roth T
Am J Gastroenterol; 2005 Sep; 100(9):1914-22. PubMed ID: 16128933
[TBL] [Abstract][Full Text] [Related]
54. Commentary: daily pantoprazole vs. esomeprazole for GERD--authors' reply.
Moraes-Filho JP; Pedroso M; Quigley EM
Aliment Pharmacol Ther; 2014 Jan; 39(2):227. PubMed ID: 24330240
[No Abstract] [Full Text] [Related]
55. Patterns of proton pump inhibitor utilization in gastroesophageal reflux disease and the effect of restrictions on reimbursement: a nationwide prescription database study.
Jonasson C; Tvete IF; Hatlebakk JG
Scand J Gastroenterol; 2013 Sep; 48(9):1010-7. PubMed ID: 23859491
[TBL] [Abstract][Full Text] [Related]
56. Meta-analysis of the effectiveness of esomeprazole in gastroesophageal reflux disease and Helicobacter pylori infection.
Teng M; Khoo AL; Zhao YJ; Lin L; Lim BP; Wu TS; Dan YY
J Clin Pharm Ther; 2015 Aug; 40(4):368-75. PubMed ID: 25893507
[TBL] [Abstract][Full Text] [Related]
57. The Prevalence and Clinical Features of Non-responsive Gastroesophageal Reflux Disease to Practical Proton Pump Inhibitor Dose in Korea: A Multicenter Study.
Park HJ; Park SH; Shim KN; Kim YS; Kim HJ; Han JP; Kim YS; Bang BW; Kim GH; Baik GH; Kim HH; Park SY; Kim SS
Korean J Gastroenterol; 2016 Jul; 68(1):16-22. PubMed ID: 27443619
[TBL] [Abstract][Full Text] [Related]
58. Esomeprazole regimens for reflux symptoms in Chinese patients with chronic gastritis.
Sun J; Yuan YZ; Hou XH; Zou DW; Lu B; Chen MH; Liu F; Wu KC; Zou XP; Li YQ; Zhou LY
World J Gastroenterol; 2015 Jun; 21(22):6965-73. PubMed ID: 26078574
[TBL] [Abstract][Full Text] [Related]
59. Long-term benefit of transoral incisionless fundoplication using the esophyx device for the management of gastroesophageal reflux disease responsive to medical therapy.
Stefanidis G; Viazis N; Kotsikoros N; Tsoukalas N; Lala E; Theocharis L; Fassaris A; Manolakopoulos S
Dis Esophagus; 2017 Feb; 30(3):1-8. PubMed ID: 27868281
[TBL] [Abstract][Full Text] [Related]
60. Long-term outcomes of patients with symptomatic gastroesophageal reflux disease treated with vonoprazan.
Shinozaki S; Osawa H; Kobayashi Y; Sakamoto H; Hayashi Y; Miura Y; Kawarai Lefor A; Yamamoto H
Scand J Gastroenterol; 2018 Aug; 53(8):897-904. PubMed ID: 30056768
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
